ARCHIVES

Clinical Trials Approved By NCI Last Month

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Coleman To Lead NCI’s New Radiation Oncology Program

February 5, 1999

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Bioassay Report Clears EDTA

August 12, 1977

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

March 24, 2006

Funding Opportunities

January 24, 2003

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992